1
|
Nindra U, Hong JH, Balakrishnar B, Pal A, Chua W. Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer. Clin Genitourin Cancer 2023; 21:183-193. [PMID: 35927195 DOI: 10.1016/j.clgc.2022.07.005] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2022] [Revised: 07/07/2022] [Accepted: 07/09/2022] [Indexed: 02/01/2023]
Abstract
There is emerging evidence for the use of poly (ADP-ribose) polymerase inhibitors (PARPi) in patients with mCRPC with patients harboring germline or somatic mutations deriving clinical benefit. However, the toxicity profile of PARPi in mCRPC is not well established. In March 2022 a literature search was conducted across 4 databases - Medline, PubMed, Cochrane Library and Embase. In total, 14 relevant studies were identified cumulating in 2066 patients that were treated with PARPi. The overall ORR to PARPi alone or in combination with other therapy was 37% (246/666). In 5trials that investigated PARPi alone, the ORR was 39% (141/361). Treatment emergent adverse events (TEAEs) of any grade were reported in 96% (1034/1080) in PARPi treatment arms. TEAEs of grade >= 3 were reported in 57% (611/1080). 45% (457/1006) experienced treatment interruption whilst 31% (310/989) required dose reductions. 11% (114/1006) of patients had their treatment discontinued directly as the result of toxicity associated with the trial medications. The most common hematological toxicity was anemia, reported in 490/1160 (42%) patients. and lowered white blood cell count were the next 2most common toxicities, reported in 186/655 (28%) and 133/729 (18%) respectively. The 3most common non-hematological toxicities reported were nausea, fatigue and anorexia reported in 440/1013 (43%), 340/1013 (34%) and 274/1013 (27%) patients respectively. Overall, TRAEs associated with individual PARPi are still emerging with hematological toxicities being most apparent. Further toxicities will be informed from future clinical trials to allow improved treatment selection, education and management of toxicities in prostate cancer.
Collapse
Affiliation(s)
- Udit Nindra
- Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia; School of Medicine, University of New South Wales, Sydney, NSW, Australia.
| | - Jun Hee Hong
- Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia; School of Medicine, University of New South Wales, Sydney, NSW, Australia
| | | | - Abhijit Pal
- Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia; School of Medicine, University of New South Wales, Sydney, NSW, Australia
| | - Wei Chua
- Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia; School of Medicine, University of New South Wales, Sydney, NSW, Australia; School of Medicine, Western Sydney University, Sydney, NSW, Australia; Ingham Institute for Applied Medical Research, Sydney, NSW, Australia
| |
Collapse
|
2
|
Hong JH, Nindra U, Nguyen R, Gassner P, Balakrishnar B, Rutland T. A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular Tumour. Case Rep Oncol 2022; 15:1055-1062. [PMID: 36605230 PMCID: PMC9808135 DOI: 10.1159/000525842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2022] [Accepted: 06/27/2022] [Indexed: 11/17/2022] Open
Abstract
Prostate adenocarcinoma with testicular metastasis is rare, present in up to 4% of autopsy diagnoses, and presents symptomatically in less than 0.5% of cases. We report an unusual case of a 55-year-old male who developed a symptomatic testicular metastasis from primary prostate cancer 4 years after initial diagnosis of metastatic castrate-sensitive prostate cancer with nodal and bone-only involvement. The patient had orchidectomy, histologically confirming the metastasis and revealing sparing of the spermatic cord. Prior treatment for his metastatic castrate-sensitive prostate cancer had included androgen deprivation therapy and upfront docetaxel chemotherapy. He had received palliative radiotherapy for symptomatic bone metastasis and managed on enzalutamide for castrate-resistant disease for the preceding 22 months with ongoing PSA response at the time of diagnosis of new testicular metastasis, with a further significant PSA response following his "testicular metastasectomy." At the time of diagnosis of testicular metastasis, he did not have any evidence of other visceral metastases, and his metastatic disease otherwise remained radiologically stable. We describe his disease course, treatment and outline the rare nature of his case of testicular metastasis from prostate cancer.
Collapse
Affiliation(s)
- Jun Hee Hong
- Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia
| | - Udit Nindra
- Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia
| | - Rebecca Nguyen
- Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia
| | - Paul Gassner
- Department of Urology, Liverpool Hospital, Sydney, NSW, Australia
| | | | - Tristan Rutland
- Department of Anatomical Pathology, Liverpool Hospital, Sydney, NSW, Australia
| |
Collapse
|
3
|
Siu DHW, O'Neill RS, Harris CA, Wang J, Ardolino L, Downton T, Tong M, Hong JH, Chin V, Clingan PR, Aghmesheh M, Soudy H. Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review. Immunotherapy 2022; 14:511-520. [PMID: 35321560 DOI: 10.2217/imt-2021-0225] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Immune checkpoint inhibitors have been incorporated into the treatment of various malignancies. An increasing body of literature is reporting rare but potentially fatal adverse events associated with these agents. In this case series, the authors report the clinical features and outcomes of seven patients who received immune checkpoint inhibitors for different solid organ malignancies and developed a tetrad of immune-related myocarditis, myositis, myasthenia gravis and transaminitis. Herein the authors review the literature and describe the current diagnostic and management approach for this overlapping syndrome. The authors' series highlights the importance of a high index of clinical suspicion, prompt comprehensive investigations, early multidisciplinary team involvement and initiation of immunosuppressive therapy when immune-related adverse events are suspected.
Collapse
Affiliation(s)
- Derrick Ho Wai Siu
- Department of Medical Oncology, St George Hospital, Kogarah, New South Wales, 2217, Australia.,National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, 2050, Australia.,Faculty of Medicine, The University of New South Wales, New South Wales, Australia
| | - Robert Sean O'Neill
- Faculty of Medicine, The University of New South Wales, New South Wales, Australia.,Department of Medical Oncology, Sutherland Hospital, Caringbah, New South Wales, 2229, Australia
| | - Carole A Harris
- Department of Medical Oncology, St George Hospital, Kogarah, New South Wales, 2217, Australia.,Faculty of Medicine, The University of New South Wales, New South Wales, Australia.,Department of Medical Oncology, Sutherland Hospital, Caringbah, New South Wales, 2229, Australia
| | - Justine Wang
- Faculty of Medicine, The University of New South Wales, New South Wales, Australia.,Department of Neurology, St George Hospital, Kogarah, New South Wales, 2217, Australia.,Institute of Neurological Sciences, Prince of Wales Hospital, Randwick, New South Wales, 2031, Australia
| | - Luke Ardolino
- Faculty of Medicine, The University of New South Wales, New South Wales, Australia.,Department of Medical Oncology, The Kinghorn Centre, St Vincent's Hospital, Darlinghurst, New South Wales, 2010, Australia
| | - Teesha Downton
- Department of Medical Oncology, The Wollongong Hospital, Wollongong, New South Wales, 2500, Australia
| | - Matthew Tong
- Department of Medical Oncology, Sutherland Hospital, Caringbah, New South Wales, 2229, Australia
| | - Jun Hee Hong
- Department of Medical Oncology, St George Hospital, Kogarah, New South Wales, 2217, Australia
| | - Venessa Chin
- Department of Medical Oncology, The Kinghorn Centre, St Vincent's Hospital, Darlinghurst, New South Wales, 2010, Australia.,Single Cell and Computational Genomics Lab, The Garvan Institute of Medical Research, Darlinghurst, New South Wales, 2010, Australia
| | - Philip R Clingan
- Department of Medical Oncology, The Wollongong Hospital, Wollongong, New South Wales, 2500, Australia.,University of Wollongong, New South Wales, Australia
| | - Morteza Aghmesheh
- Department of Medical Oncology, The Wollongong Hospital, Wollongong, New South Wales, 2500, Australia.,University of Wollongong, New South Wales, Australia
| | - Hussein Soudy
- Department of Medical Oncology, St George Hospital, Kogarah, New South Wales, 2217, Australia.,Faculty of Medicine, The University of New South Wales, New South Wales, Australia.,Department of Medical Oncology, Sutherland Hospital, Caringbah, New South Wales, 2229, Australia
| |
Collapse
|
4
|
Sung P, Yoon SH, Kim J, Hong JH, Park S, Goo JM. Bronchovascular bundle thickening on CT as a predictor of survival and brain metastasis in patients with stage IA peripheral small cell lung cancer. Clin Radiol 2020; 76:76.e37-76.e46. [PMID: 32948314 DOI: 10.1016/j.crad.2020.08.018] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Accepted: 08/19/2020] [Indexed: 01/03/2023]
Abstract
AIM To determine if bronchovascular bundle (BVB) thickening on pretreatment computed tomography (CT) images helps predict survival in patients with peripheral small cell lung cancer (pSCLC) ≤3 cm. MATERIALS AND METHODS The pretreatment CT examinations of 79 histopathologically proven pSCLC ≤3 cm (TNM stage I, 21; II, 13; III, 22; IV, 23) were reviewed retrospectively. The CT characteristics of the nodule and associated findings, including BVB thickening, were evaluated. Progression-free survival (PFS), overall survival (OS), and brain metastasis-free survival were compared with the presence of BVB thickening using Kaplan-Meier and Cox regression analysis. RESULTS Among the 79 patients, 34 (43%) had BVB thickening. BVB thickening was prevalent in patients with mediastinal lymph node metastasis (50.9% versus 22.7%; p=0.024) and distant metastasis (60.9% versus 35.7%; p=0.049). Out of the 21 patients with TNM stage IA disease, the 16 patients (76.2%) without BVB thickening showed better PFS, OS, and brain metastasis-free survival (mean, 1,762 versus 483 days; p=0.019: 2,243 versus 1,328 days; p=0.038: 2,274 versus 1,287 days; p=0.038, respectively). Multivariate Cox regression analysis showed that the absence of BVB thickening (hazard ratio [HR], 7.806; 95% CI, 1.241-49.091; p=0.029) and surgery (HR, 0.075; 95% CI, 0.008-0.746; p=0.027) were independent and useful prognostic factors for PFS. CONCLUSIONS BVB thickening was found more frequently in patients with advanced-stage pSCLC ≤3 cm, and the PFS was more favourable in patients without BVB thickening, with a similar tendency to that of OS and brain metastasis-free survival, in stage IA pSCLC.
Collapse
Affiliation(s)
- P Sung
- Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea
| | - S H Yoon
- Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea; Department of Radiology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 030804, South Korea.
| | - J Kim
- Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 300 Gumi-dong, Bundang-gu, Seongnam, Gyeonggi-do, 13620, South Korea
| | - J H Hong
- Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea
| | - S Park
- Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
| | - J M Goo
- Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea; Department of Radiology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 030804, South Korea; Institute of Radiation Medicine, Seoul National University Medical Research Center, 103 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea
| |
Collapse
|
5
|
Lee BK, Hong JH. Temporomandibular joint disc plication with MITEK mini anchors: surgical outcome of 65 consecutive joint cases using a minimally invasive approach. Maxillofac Plast Reconstr Surg 2020; 42:14. [PMID: 32368527 PMCID: PMC7190784 DOI: 10.1186/s40902-020-00259-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2020] [Accepted: 04/15/2020] [Indexed: 11/10/2022] Open
Abstract
Background The purpose of this study is to introduce our modified disc plication technique using MITEK mini anchors and to evaluate the clinical outcome for patients with internal derangement (ID) of the temporomandibular joint (TMJ). Patients and methods We evaluated 65 joints in 46 patients, comprised 32 women and 14 men, who first visited the Asan Medical Center from December 2012 to December 2016. The age of the patients ranged from 14 to 79 years, with a mean age of 36.6 years. The patients presented with joint problems including pain, joint noise, and mouth opening limitation (MOL). Patients who met our inclusion criteria underwent unilateral or bilateral disc repositioning surgery with our minimally invasive disc plication technique using MITEK mini anchors and No. 2-0 Ethibond® braided polyester sutures. The variables taken into account in this study were the range of maximum mouth opening (MMO), painful symptoms (evaluated with the visual analog scale, VAS), and the type of noise (click, popping, crepitus) in the TMJ. Results Preoperative examination revealed painful symptoms in 50.7% (n = 35) of the operated joints (n = 69) and the presence of clicks in 56.5% (n = 39). Postoperative examination revealed that 4.3% (n = 3) of the operated joints had painful symptoms with lower intensity than that in the preoperative condition. Additionally, 17.4% (n = 12) had residual noise in the TMJ, among which two were clicking and the other 10 had mild crepitus. The intensity of the postoperative residual noise was significantly decreased in all cases compared to that in the preoperative condition. Among patients with MOL below 38 mm (n = 18), the mean MMO was 31.4 mm preoperatively and 44.2 mm at 6 months postoperatively, with a mean increase of 13.8 mm. A barely visible scar at the operation site was noted during the postoperative observation period, with no significant complications such as facial palsy or permanent occlusal disharmony. Conclusion Subjective symptoms in all patients improved following the surgery. TMJ disc plication using MITEK mini anchors with our minimally invasive approach may be a feasible and effective surgical option for treating TMJ ID patients who are not responsive to conservative treatment.
Collapse
Affiliation(s)
- Bu-Kyu Lee
- 1Department of Oral and Maxillofacial Surgery, Asan Medical Center, College of Medicine, University of Ulsan, 05505, Olympic-ro 88, 43-gil, Songpa-gu, Seoul, Republic of Korea.,2Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, College of Medicine, University of Ulsan, 05505, Olympic-ro 88, 43-gil, Songpa-gu, Seoul, Republic of Korea
| | - Jun Hee Hong
- 1Department of Oral and Maxillofacial Surgery, Asan Medical Center, College of Medicine, University of Ulsan, 05505, Olympic-ro 88, 43-gil, Songpa-gu, Seoul, Republic of Korea
| |
Collapse
|
6
|
Snyders K, Cho D, Hong JH, Lord S, Asher R, Marschner I, Lee CK. Benchmarking single-arm studies against historical controls from non-small cell lung cancer trials - an empirical analysis of bias. Acta Oncol 2020; 59:90-95. [PMID: 31608733 DOI: 10.1080/0284186x.2019.1674452] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Background: Recent trials of novel agents in 'rare' molecular subtypes of non-small cell lung cancer (NSCLC) have used single-arm trial designs and benchmarked outcomes against historical controls. We assessed the consistency of historical control outcomes using docetaxel data from published NSCLC randomized controlled trials (RCTs).Material and methods: Advanced NSCLC RCTs including a docetaxel monotherapy arm were included. Heterogeneity in tumor objective response rates (ORRs), progression-free survival (PFS) and overall survival (OS), and correlations between outcomes and year of trial commencement were assessed.Results: Among 63 trials (N = 10,633) conducted between 2000 and 2017, ORR ranged from 0% to 26% (I2 = 76.1%, pheterogeneity < .0001). Mean of the median PFS was 3.0 months (range: 1.4-6.4), 3-month PFS ranged from 25% to 85% (I2 = 86.0%, pheterogeneity < .0001). Mean of the median OS was 9.1 months (range: 4.7-22.9), 9-month OS ranged from 23% to 79% (I2 = 83.0%, pheterogeneity < .0001). Each later year of trial commencement was associated with 0.3% (p = .046), 0.5% (p = .11) and 0.9% (p = .001) improvement in ORR, 3-month PFS and 9-month OS rates, respectively.Conclusions: There was significant heterogeneity and an improving trend in docetaxel outcomes across trials conducted over 20 years. Benchmarking biomarker-targeted agents against historical controls may not be a valid approach to replace RCTs. Innovative study designs involving a concurrent control arm should be considered.
Collapse
Affiliation(s)
- Kelli Snyders
- Cancer Care Centre, St George Hospital, Kogarah, Australia
| | - Doah Cho
- National Health and Medical Research Council Clinical Trials Centre, Camperdown, Australia
| | - Jun Hee Hong
- Cancer Care Centre, St George Hospital, Kogarah, Australia
| | - Sally Lord
- National Health and Medical Research Council Clinical Trials Centre, Camperdown, Australia
- School of Medicine, The University of Norte Dame, Darlinghurst, Australia
| | - Rebecca Asher
- National Health and Medical Research Council Clinical Trials Centre, Camperdown, Australia
| | - Ian Marschner
- National Health and Medical Research Council Clinical Trials Centre, Camperdown, Australia
- Department of Statistics, Macquarie University, Sydney, Australia
| | - Chee Khoon Lee
- Cancer Care Centre, St George Hospital, Kogarah, Australia
- National Health and Medical Research Council Clinical Trials Centre, Camperdown, Australia
| |
Collapse
|
7
|
Kim ST, Kang JH, Lee J, Lee HW, Oh SY, Jang JS, Lee MA, Sohn BS, Yoon SY, Choi HJ, Hong JH, Kim MJ, Kim S, Park YS, Park JO, Lim HY. Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial. Ann Oncol 2019; 30:788-795. [PMID: 30785198 DOI: 10.1093/annonc/mdz058] [Citation(s) in RCA: 56] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND Capecitabine plus oxaliplatin (XELOX) has shown modest activity and tolerable toxicity in a phase II trial for biliary tract cancers (BTCs). Meanwhile, gemcitabine plus oxaliplatin (GEMOX) has been the reference arm in recent phase II and III trials for BTCs. We aimed to investigate the efficacy of XELOX versus GEMOX as first-line therapy for advanced BCTs. PATIENTS AND METHODS In this open-label, randomized, phase III, noninferiority trial, we randomly selected patients with metastatic BCTs to receive GEMOX (gemcitabine 1000 mg/m2 on days 1 and 8, and oxaliplatin 100 mg/m2 on day 1) or XELOX (capecitabine 1000 mg/m2, twice daily, on days 1-14 and oxaliplatin 130 mg/m2 on day 1) as first-line treatment, given every 3 weeks, totaling eight cycles. The primary end point was to prove the noninferiority of XELOX to GEMOX in terms of 6-month progression-free survival (PFS) rate. RESULTS In total, 114 patients randomly received GEMOX and 108 randomly received XELOX. The median PFS was 5.3 months for the GEMOX group and 5.8 months for the XELOX group. The 6-month PFS rate was 44.5% for the GEMOX group and 46.7% for the XELOX group. The 95% confidence interval of the 6-month PFS rate difference between both groups was -12% to 16%, meeting the criteria for noninferiority of XELOX to GEMOX. There was no difference in objective response (P=0.171) and median overall survival (P=0.131) between both groups. The most common grade three to four adverse events were neutropenia and thrombocytopenia. No patient died of treatment-related causes. The XELOX group had significantly lower frequencies of hospital visits than the GEMOX group (P<0.001). CONCLUSION XELOX showed significant noninferiority to GEMOX in terms of 6-month PFS rate. Thus, XELOX could be an alternative first-line treatment of BCTs. TRIAL REGISTRATION This study was registered in ClinicalTrials.gov (number NCT01470443).
Collapse
Affiliation(s)
- S T Kim
- Division of Hemato-oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul
| | - J H Kang
- Division of Hemato-oncology, Department of Medicine, Gyeongsang National University Hospital, Jinju
| | - J Lee
- Division of Hemato-oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul
| | - H W Lee
- Division of Hemato-oncology, Department of Medicine, Ajou University School of Medicine, Suwon
| | - S Y Oh
- Division of Hemato-oncology, Department of Medicine, Dong-A University School of Medicine, Busan
| | - J S Jang
- Division of Hemato-oncology, Department of Medicine, Chung-Ang University College of Medicine, Seoul
| | - M A Lee
- Division of Hemato-oncology, Department of Medicine, Seoul St Mary's Hospital, Catholic University, Seoul
| | - B S Sohn
- Division of Hemato-oncology, Department of Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul
| | - S Y Yoon
- Division of Hemato-oncology, Department of Medicine, Konkuk University Medical Center, Seoul
| | - H J Choi
- Division of Hemato-oncology, Department of Medicine, Yonsei University College of Medicine, Seoul
| | - J H Hong
- Division of Hemato-oncology, Department of Medicine, Incheon St Mary's Hospital, Catholic University, Incheon
| | - M-J Kim
- Statistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea
| | - S Kim
- Statistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea
| | - Y S Park
- Division of Hemato-oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul
| | - J O Park
- Division of Hemato-oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul.
| | - H Y Lim
- Division of Hemato-oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul.
| |
Collapse
|
8
|
Hong JH, Charles ST. WELL-BEING AND AGE: A COMPARISON OF TWO CULTURES. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- J H Hong
- University of California, Irvine, Irvine, California, United States
| | - S T Charles
- University of California, Irvine, Irvine, CA, USA
| |
Collapse
|
9
|
Charles S, Hong JH, Leger KA, Fingerman K. GETTING BY WITH A LITTLE HELP FROM MY FRIENDS: FUNCTIONAL LIMITATIONS AND DAILY EMOTIONAL EXPERIENCES. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- S Charles
- The University of California, Irvine, Irvine, California, United States
| | - J H Hong
- University of California, Irvine, CA, USA
| | - K A Leger
- University of California, Irvine, CA, USA
| | - K Fingerman
- The University of Texas at Austin, Austin, TX, USA
| |
Collapse
|
10
|
You Y, Hong JH, Yin J, Oh YT, Kim SS, Park JB. Abstract 1133: Mitochondria localized EGFRvIII promotes stemness through regulation of mitochondrial dynamics in glioblastoma stem cells. Cancer Res 2018. [DOI: 10.1158/1538-7445.am2018-1133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose Changes in mitochondrial morphology have been linked with mitochondrial function and host cell homeostasis in many metabolic diseases. Cancer is increasingly perceived as metabolic disease, so understanding and regulating mitochondrial dynamics is of interest in cancer therapeutics. Recent studies indicate that distinct metabolic profile of cancer is dependent on genes that regulate the fusion and fission of mitochondria. Importantly, high levels of mitochondrial fission activity are common in cancer cell malignancy and in stem cell′s resistance to differentiation. Since these two phenotypes converge into cancer stem cells, investigating mitochondrial fission activity will provide hints to target cancer stem cell in therapeutics. Purpose of this study is to elucidate what regulates mitochondrial dynamics in cancer stem cells to sustain their stemness properties. In GBM, amplification of the oncogenic variant of EGFR, EGFRvIII, is associated with poor patient prognosis and has recently been known as the major contributor for stemness. Thus, we investigated the role of this oncogenic change in mitochondrial dynamics and stemness control in glioblastoma stem cells (GSCs). Methods Patient-derived GSCs were cultured and sorted by FACS based on tetramethylrhodamine ethyl ester (TMRE) dye emission level, which indicates mitochondrial membrane potential and functional activeness. The highest and the lowest TMRE groups each was collected and subject to further experiments. siRNA was used for loss-of-function study and lentivirus containing overexpression vector was used for gain-of-function study. In order to show the effect of EGFRvIII kinase activity inhibition, gefitinib and its derivative were used.
Results High TMRE GSCs showed stronger self-renewal ability in spheroid culture and higher levels of stemness marker Nestin, EGFRvIII, and mitochondrial fission regulator DRP1 expression than low TMRE GSCs. The high TMRE GSCs also showed more fragmented mitochondrial pattern, indicative of active mitochondrial fission. As underlying mechanism of EGFRvIII action on mitochondrial membrane potential, we figured out that EGFRvIII is localized at mitochondria. In order target mitochondria localized EGFRvIII, we used a gefitinib derivative which has mitochondria targeting moiety. This drug reduced mitochondrial membrane potential, self-renewal property, protein levels that regulate mitochondrial dynamics and less fragmented mitochondria, compared to gefitinib treated cells.
Conclusion EGFRvIII promotes self-renewal property of GSCs by translocating to mitochondria and upregulating mitochondrial membrane potential and fission-related protein levels. This finding highlights the role of mitochondrial dynamics as a mediator mechanism between tumor-specific oncogenic change and stem cell self-renewal ability.
Citation Format: Yeonhee You, Jun Hee Hong, Jinlong Yin, Young Taek Oh, Sung Soo Kim, Jong Bae Park. Mitochondria localized EGFRvIII promotes stemness through regulation of mitochondrial dynamics in glioblastoma stem cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 1133.
Collapse
Affiliation(s)
- Yeonhee You
- 1National Cancer Center Graduate School of Cancer Science and Policy, Goyang-si, Republic of Korea
| | - Jun Hee Hong
- 2National Cancer Center, Goyang-si, Republic of Korea
| | - Jinlong Yin
- 2National Cancer Center, Goyang-si, Republic of Korea
| | - Young Taek Oh
- 2National Cancer Center, Goyang-si, Republic of Korea
| | - Sung Soo Kim
- 1National Cancer Center Graduate School of Cancer Science and Policy, Goyang-si, Republic of Korea
| | - Jong Bae Park
- 1National Cancer Center Graduate School of Cancer Science and Policy, Goyang-si, Republic of Korea
| |
Collapse
|
11
|
Moor RJ, Roberts KE, Mason R, Gunawan B, Feng S, Hong JH, Von Itzstein M, Hughes BGM, Lwin Z, Jain VK, Bigby KJ, Azer MWF, Sanmugarajah J, O'Byrne KJ. Immune-related adverse events and nivolumab outcomes in non-small cell lung cancer patients: A multi-institutional, retrospective cohort study. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.9067] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Rebecca Jane Moor
- Princess Alexandra Hospital & University of Queensland, Brisbane, Australia
| | | | - Robert Mason
- Princess Alexandra Hospital & University of Queensland, Brisbane, Australia
| | - Ben Gunawan
- Sunshine Coast University Hospital, Queensland, AU
| | | | - Jun Hee Hong
- Gold Coast University Hospital, Queensland, Australia
| | | | | | - Zarnie Lwin
- Royal Brisbane & Women's' Hospital, Queensland, Australia
| | | | | | | | | | - Kenneth John O'Byrne
- Princess Alexandra Hospital & Queensland University of Technology, Brisbane, Australia
| |
Collapse
|
12
|
Abstract
Pneumomediastinum is an uncommon radiographic finding resulting from various causes, such as trauma, infection and unknown causes. The pneumomediastinum due to minor trauma is rarely reported and treatment and diagnostic process is not established. We report on a 20-year-old female patient who initially presented with neck pain and dyspnoea following manual strangulation. Her chest X-ray and computed tomography (CT) of neck imaging showed subcutaneous emphysema and extensive pneumomediastinum, but pneumothorax was not shown. She was transferred to the thoracic surgery and admitted to the general ward. The patient's condition improved and she was discharged on the sixth hospital day. In conclusion, patients with pneumomediastinum following a minor strangulation injury can be observed alone without invasive testing or repeated imaging. CT scans are of great value for safe observation in determined patients and for the further evaluation of pneumomediastinum.
Collapse
Affiliation(s)
| | | | | | - JH Hong
- Chung-Ang University Hosiptal, Department of Thoracic and Cardiovascular Surgery, College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, Korea
| | | | | |
Collapse
|
13
|
Seon CR, Hong JH, Song I, Jang J, Lee HY, An YH, Kim BS, Jeon TM, Park JS, Choe W, Lee HG, Pak S, Cheon MS, Choi JH, Kim HS, Biel W, Bernascolle P, Barnsley R. VUV spectroscopy in impurity injection experiments at KSTAR using prototype ITER VUV spectrometer. Rev Sci Instrum 2017; 88:083511. [PMID: 28863699 DOI: 10.1063/1.4998970] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The ITER vacuum ultra-violet (VUV) core survey spectrometer has been designed as a 5-channel spectral system so that the high spectral resolving power of 200-500 could be achieved in the wavelength range of 2.4-160 nm. To verify the design of the ITER VUV core survey spectrometer, a two-channel prototype spectrometer was developed. As a subsequent step of the prototype test, the prototype VUV spectrometer has been operated at KSTAR since the 2012 experimental campaign. From impurity injection experiments in the years 2015 and 2016, strong emission lines, such as Kr xxv 15.8 nm, Kr xxvi 17.9 nm, Ne vii 46.5 nm, Ne vi 40.2 nm, and an array of largely unresolved tungsten lines (14-32 nm) could be measured successfully, showing the typical photon number of 1013-1015 photons/cm2 s.
Collapse
Affiliation(s)
- C R Seon
- National Fusion Research Institute, Gwahangno, 169-148 Yuseong-gu, Daejeon, South Korea
| | - J H Hong
- Korea Advanced Institute of Science and Technology, Daehak-ro, 291 Yuseong-gu, Daejeon, South Korea
| | - I Song
- Korea Advanced Institute of Science and Technology, Daehak-ro, 291 Yuseong-gu, Daejeon, South Korea
| | - J Jang
- Korea Advanced Institute of Science and Technology, Daehak-ro, 291 Yuseong-gu, Daejeon, South Korea
| | - H Y Lee
- Korea Advanced Institute of Science and Technology, Daehak-ro, 291 Yuseong-gu, Daejeon, South Korea
| | - Y H An
- National Fusion Research Institute, Gwahangno, 169-148 Yuseong-gu, Daejeon, South Korea
| | - B S Kim
- Department of Energy Systems Research, Ajou University, Suwon 443-749, South Korea
| | - T M Jeon
- Korea Advanced Institute of Science and Technology, Daehak-ro, 291 Yuseong-gu, Daejeon, South Korea
| | - J S Park
- Korea Advanced Institute of Science and Technology, Daehak-ro, 291 Yuseong-gu, Daejeon, South Korea
| | - W Choe
- Korea Advanced Institute of Science and Technology, Daehak-ro, 291 Yuseong-gu, Daejeon, South Korea
| | - H G Lee
- National Fusion Research Institute, Gwahangno, 169-148 Yuseong-gu, Daejeon, South Korea
| | - S Pak
- National Fusion Research Institute, Gwahangno, 169-148 Yuseong-gu, Daejeon, South Korea
| | - M S Cheon
- National Fusion Research Institute, Gwahangno, 169-148 Yuseong-gu, Daejeon, South Korea
| | - J H Choi
- National Fusion Research Institute, Gwahangno, 169-148 Yuseong-gu, Daejeon, South Korea
| | - H S Kim
- National Fusion Research Institute, Gwahangno, 169-148 Yuseong-gu, Daejeon, South Korea
| | - W Biel
- Institut für Plasmaphysik, Forschungszentrum Jülich Gmbh, EURATOM Association, Trilateral Euregio Cluster, D-52425 Jülich, Germany
| | - P Bernascolle
- ITER Organization, Route de Vinon-sur-Verdon - CS 90 046, 13067 Saint-Paul-lez-Durance, France
| | - R Barnsley
- ITER Organization, Route de Vinon-sur-Verdon - CS 90 046, 13067 Saint-Paul-lez-Durance, France
| |
Collapse
|
14
|
Yin J, Oh YT, Kim JY, Kim SS, Choi E, Kim TH, Hong JH, Chang N, Cho HJ, Sa JK, Kim JC, Kwon HJ, Park S, Lin W, Nakano I, Gwak HS, Yoo H, Lee SH, Lee J, Kim JH, Kim SY, Nam DH, Park MJ, Park JB. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling. Cancer Res 2017; 77:4973-4984. [PMID: 28754668 DOI: 10.1158/0008-5472.can-17-0388] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2017] [Revised: 05/30/2017] [Accepted: 07/11/2017] [Indexed: 11/16/2022]
Abstract
Necrosis is a hallmark of glioblastoma (GBM) and is responsible for poor prognosis and resistance to conventional therapies. However, the molecular mechanisms underlying necrotic microenvironment-induced malignancy of GBM have not been elucidated. Here, we report that transglutaminase 2 (TGM2) is upregulated in the perinecrotic region of GBM and triggered mesenchymal (MES) transdifferentiation of glioma stem cells (GSC) by regulating master transcription factors (TF), such as C/EBPβ, TAZ, and STAT3. TGM2 expression was induced by macrophages/microglia-derived cytokines via NF-κB activation and further degraded DNA damage-inducible transcript 3 (GADD153) to induce C/EBPβ expression, resulting in expression of the MES transcriptome. Downregulation of TGM2 decreased sphere-forming ability, tumor size, and radioresistance and survival in a xenograft mouse model through a loss of the MES signature. A TGM2-specific inhibitor GK921 blocked MES transdifferentiation and showed significant therapeutic efficacy in mouse models of GSC. Moreover, TGM2 expression was significantly increased in recurrent MES patients and inversely correlated with patient prognosis. Collectively, our results indicate that TGM2 is a key molecular switch of necrosis-induced MES transdifferentiation and an important therapeutic target for MES GBM. Cancer Res; 77(18); 4973-84. ©2017 AACR.
Collapse
Affiliation(s)
- Jinlong Yin
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.,Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Young Taek Oh
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea.,Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea
| | - Jeong-Yub Kim
- Division of Radiation Cancer Research, Research Center for Radio-Senescence, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.,Department of Pathology, College of Medicine, Korea University, Seoul, Korea
| | - Sung Soo Kim
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
| | - Eunji Choi
- Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
| | - Tae Hoon Kim
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Jun Hee Hong
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Nakho Chang
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.,Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea
| | - Hee Jin Cho
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.,Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea
| | - Jason K Sa
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.,Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea
| | - Jeong Cheol Kim
- Division of Radiation Cancer Research, Research Center for Radio-Senescence, Korea Institute of Radiological and Medical Sciences, Seoul, Korea
| | - Hyung Joon Kwon
- Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
| | - Saewhan Park
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
| | - Weiwei Lin
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
| | - Ichiro Nakano
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama.,UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama
| | - Ho-Shin Gwak
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.,Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Heon Yoo
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.,Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Seung-Hoon Lee
- Department of Neurosurgery, Eulji University School of Medicine, Daejeon, Korea
| | - Jeongwu Lee
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
| | - Jong Heon Kim
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.,Cancer Cell and Molecular Biology Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Soo-Youl Kim
- Cancer Cell and Molecular Biology Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Do-Hyun Nam
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea. .,Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.,Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Myung-Jin Park
- Division of Radiation Cancer Research, Research Center for Radio-Senescence, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
| | - Jong Bae Park
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea. .,Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| |
Collapse
|
15
|
Shin DH, Kim YS, Yoo DS, Kim MJ, Oh CS, Hong JH, Lee E, Chai JY, Seo M. A Case of Ectopic Paragonimiasis in a 17th Century Korean Mummy. J Parasitol 2017; 103:399-403. [PMID: 28395568 DOI: 10.1645/16-63] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Archaeoparasitological studies on fossilized feces obtained from Joseon Dynasty (1392-1910 CE) mummies have provided invaluable data on the patterns of parasitic infection in pre-modern Korean societies. In our recent radiological investigation of a 17th century Joseon mummy discovered in Cheongdo (South Korea), we located a liver mass just below the diaphragm. Anatomical dissection confirmed the presence of a mass of unknown etiology. A subsequent parasitological examination of a sample of the mass revealed a large number of ancient Paragonimus sp. eggs, making the current report the first archaeoparasitological case of liver abscess caused by ectopic paragonimiasis.
Collapse
Affiliation(s)
- D H Shin
- Bioanthropology and Paleopathology Lab, Institute of Forensic Science, Seoul National University College of Medicine, 103 Daehak-ro (Yongon-dong), Jongno-gu, Seoul 03080, South Korea. Correspondence should be sent to M. Seo at:
| | - Y-S Kim
- Bioanthropology and Paleopathology Lab, Institute of Forensic Science, Seoul National University College of Medicine, 103 Daehak-ro (Yongon-dong), Jongno-gu, Seoul 03080, South Korea. Correspondence should be sent to M. Seo at:
| | - D S Yoo
- Bioanthropology and Paleopathology Lab, Institute of Forensic Science, Seoul National University College of Medicine, 103 Daehak-ro (Yongon-dong), Jongno-gu, Seoul 03080, South Korea. Correspondence should be sent to M. Seo at:
| | - M J Kim
- Bioanthropology and Paleopathology Lab, Institute of Forensic Science, Seoul National University College of Medicine, 103 Daehak-ro (Yongon-dong), Jongno-gu, Seoul 03080, South Korea. Correspondence should be sent to M. Seo at:
| | - C S Oh
- Bioanthropology and Paleopathology Lab, Institute of Forensic Science, Seoul National University College of Medicine, 103 Daehak-ro (Yongon-dong), Jongno-gu, Seoul 03080, South Korea. Correspondence should be sent to M. Seo at:
| | - J H Hong
- Bioanthropology and Paleopathology Lab, Institute of Forensic Science, Seoul National University College of Medicine, 103 Daehak-ro (Yongon-dong), Jongno-gu, Seoul 03080, South Korea. Correspondence should be sent to M. Seo at:
| | - E Lee
- Bioanthropology and Paleopathology Lab, Institute of Forensic Science, Seoul National University College of Medicine, 103 Daehak-ro (Yongon-dong), Jongno-gu, Seoul 03080, South Korea. Correspondence should be sent to M. Seo at:
| | - J Y Chai
- Bioanthropology and Paleopathology Lab, Institute of Forensic Science, Seoul National University College of Medicine, 103 Daehak-ro (Yongon-dong), Jongno-gu, Seoul 03080, South Korea. Correspondence should be sent to M. Seo at:
| | - M Seo
- Bioanthropology and Paleopathology Lab, Institute of Forensic Science, Seoul National University College of Medicine, 103 Daehak-ro (Yongon-dong), Jongno-gu, Seoul 03080, South Korea. Correspondence should be sent to M. Seo at:
| |
Collapse
|
16
|
Oh YT, Hong JH, Park JB. Abstract A09: The role of pre-mRNA splicing factor in Glioblastoma Multiforme by regulating EGFRvIII. Cancer Res 2017. [DOI: 10.1158/1538-7445.transcontrol16-a09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Glioblastoma (GBM) heterogeneity in the genomic and phenotypic properties has potentiated personalized approach against specific therapeutic targets of each GBM patient. Therefore, there is a critical unmet need to predict therapeutic responses for individual patients. There is 50% of GBM patient has EGFR over-expression and mutation. Because of this reason, there are various EGFRvIII target inhibitor for GBM patient. However, the efficacy of EGFRvIII specific drugs is not good because of autophosphorylation. We found Tra2β, which is pre-mRNA splicing factor, can bind in first intron and there are 9 consensus sequences. Because of EGFRvIII has deletion of second exon, Tra2β can regulate the expression of EGFRvIII. We validated low WTAP expression level in differentiated GBM stem cells, and confirmed the tumorigenic function of Tra2β in GBM cells. Furthermore, we are going to find the mechanism of Tra2β that can regulated by CDC-like kinase. As a result, we connected Tra2β function and EGFR specific drug resistance problem. This study could be helpful on personalized treatment approach based on genetic characteristics of each GBM could make better treatment outcomes of GBMs.
Citation Format: Young Taek Oh, Jun Hee Hong, Jong Bae Park. The role of pre-mRNA splicing factor in Glioblastoma Multiforme by regulating EGFRvIII. [abstract]. In: Proceedings of the AACR Special Conference on Translational Control of Cancer: A New Frontier in Cancer Biology and Therapy; 2016 Oct 27-30; San Francisco, CA. Philadelphia (PA): AACR; Cancer Res 2017;77(6 Suppl):Abstract nr A09.
Collapse
Affiliation(s)
- Young Taek Oh
- National Cancer Center, Goyang-Si, Korea, Republic Of
| | - Jun Hee Hong
- National Cancer Center, Goyang-Si, Korea, Republic Of
| | - Jong Bae Park
- National Cancer Center, Goyang-Si, Korea, Republic Of
| |
Collapse
|
17
|
Lee S, Park HT, Hong JH, Song JY, Lee JK, Kim T. Paratubal Borderline Malignancy in an Adolescent Female Treated with Laparo-Endoscopic Single-Site Surgery (LESS) and a Review of the Literature. J Minim Invasive Gynecol 2016. [DOI: 10.1016/j.jmig.2016.08.702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
18
|
Chung SP, Yune HY, Park YS, You JS, Hong JH, Kong T, Park JW, Chung HS, Park I. Usefulness of mean platelet volume as a marker for clinical outcomes after out-of-hospital cardiac arrest: a retrospective cohort study. J Thromb Haemost 2016; 14:2036-2044. [PMID: 27437641 DOI: 10.1111/jth.13421] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2015] [Accepted: 06/27/2016] [Indexed: 01/06/2023]
Abstract
Essentials It is unknown whether mean platelet volume (MPV) estimates outcomes after cardiac arrest (CA). We investigated whether MPV was associated with 30-day neurologic outcome and mortality after CA. Elevated MPV at admission was associated with poor neurological outcomes and mortality at 30 days. Identifying levels of MPV is helpful for estimating disease severity among resuscitated patients. SUMMARY Background Whole-body ischemia followed by reperfusion during cardiac arrest and after return of spontaneous circulation (ROSC) triggers systemic sterile inflammatory responses, inducing a sepsis-like state during post-cardiac arrest syndrome. Activated platelets are enlarged, and contain vasoactive and prothrombic factors that aggravate systemic inflammation and endothelial dysfunction. Objectives To investigate whether mean platelet volume (MPV) is useful as a marker for early mortality and neurologic outcomes in patients who achieve ROSC after out-of-hospital cardiac arrest (OHCA). Methods OHCA records from the Emergency Department Cardiac Arrest Registry were retrospectively analyzed. Patients who survived for > 24 h after ROSC were included. We evaluated mortality and cerebral performance category scores after 30 days. Results We analyzed records from 184 patients with OHCA. Increased 30-day mortality among patients who achieved ROSC after OHCA was associated with MPV at admission (hazard ratio [HR] 1.36; 95% confidence interval [CI] 1.06-1.75). An elevated MPV at admission was also associated with poor neurologic outcomes (HR 1.28; 95% CI 1.06-1.55). Conclusions An elevated MPV was independently associated with increased 30-day mortality, with the highest discriminative value being obtained upon admission after OHCA. An elevated MPV on admission was associated with poor neurologic outcomes. High MPVs are helpful for estimating 30-day mortality and neurologic outcomes among patients who achieve ROSC after OHCA.
Collapse
Affiliation(s)
- S P Chung
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, Korea
| | - H Y Yune
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, Korea
| | - Y S Park
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, Korea
| | - J S You
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, Korea.
| | - J H Hong
- Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea
| | - T Kong
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, Korea
| | - J W Park
- Department of Emergency Medicine, Kosin University College of Medicine, Busan, Korea
| | - H S Chung
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, Korea
| | - I Park
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, Korea
| |
Collapse
|
19
|
Koo YJ, Min KJ, Hong JH, Lee JK. Age at Diagnosis and Mass Size as Clinical Indications for Hysteroscopic Mass Excision. J Minim Invasive Gynecol 2015; 22:S188. [DOI: 10.1016/j.jmig.2015.08.687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
20
|
Lee JL, Kim MK, Park I, Ahn JH, Lee DH, Ryoo HM, Song C, Hong B, Hong JH, Ahn H. RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial. Ann Oncol 2015; 26:2300-5. [PMID: 26347107 DOI: 10.1093/annonc/mdv357] [Citation(s) in RCA: 81] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2015] [Accepted: 08/19/2015] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND The standard sunitinib schedule, 4 weeks on, followed by 2 weeks off (4/2 schedule), is associated with troublesome toxicities, and maintenance of adequate sunitinib dosing and drug levels, which are essential for achieving an optimal treatment outcome, is challenging. The objective of this study was to investigate the efficacy and safety of an alternative sunitinib dosing schedule of 2 weeks on and 1 week off (2/1 schedule) compared with the standard sunitinib schedule of 4 weeks on and 2 weeks off (4/2 schedule). PATIENTS AND METHODS In this multicenter, randomized, open-label, phase II trial, treatment-naïve patients with clear-cell type metastatic renal cell carcinoma (mRCC) were randomly assigned to 4/2 or 2/1 schedules after stratification by Memorial Sloan Kettering Cancer Center risk group and the presence or absence of measurable lesions. The primary end point was the 6-month failure-free survival (FFS) rate, determined by intention-to-treat analysis. RESULTS From November 2007 to February 2014, 76 patients were accrued, and 74 were eligible. FFS rates at 6 months were 44% with the 4/2 schedule (N = 36) and 63% with the 2/1 schedule (N = 38). Neutropenia (all grades, 61% versus 37%; grade 3-4, 28% versus 11%) and fatigue (all grades, 83% versus 58%) were more frequently observed with schedule 4/2. There was a strong tendency toward a lower incidence of stomatitis, hand-foot syndrome, and rash with schedule 2/1. Objective response rates (ORRs) were 47% in schedule 2/1 and 36% in schedule 4/2. With a median follow-up of 30.0 months, the median time to progression (TTP) was 12.1 months in schedule 2/1 and 10.1 months in schedule 4/2. CONCLUSION Sunitinib administered with a 2/1 schedule is associated with less toxicity and higher FFS at 6 months than a 4/2 schedule, without compromising the efficacy in terms of ORR and TTP (NCT00570882).
Collapse
Affiliation(s)
- J L Lee
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
| | - M K Kim
- Department of Hematology and Oncology, Yeungnam University College of Medicine, Daegu
| | - I Park
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul Department of Internal Medicine, Gachon University Gil Medical Center, Inchon
| | - J-H Ahn
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
| | - D H Lee
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
| | - H M Ryoo
- Department of Hematology and Oncology, Daegu Catholic University Medical Center, Daegu
| | - C Song
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - B Hong
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - J H Hong
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - H Ahn
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| |
Collapse
|
21
|
Yin J, Park G, Lee JE, Choi EY, Park JY, Kim TH, Park N, Jin X, Jung JE, Shin D, Hong JH, Kim H, Yoo H, Lee SH, Kim YJ, Park JB, Kim JH. DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis. Brain 2015; 138:2553-70. [DOI: 10.1093/brain/awv167] [Citation(s) in RCA: 49] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2015] [Accepted: 04/17/2015] [Indexed: 01/01/2023] Open
|
22
|
Yin J, Park G, Kim TH, Hong JH, Kim YJ, Jin X, Kang S, Jung JE, Kim JY, Yun H, Lee JE, Kim M, Chung J, Kim H, Nakano I, Gwak HS, Yoo H, Yoo BC, Kim JH, Hur EM, Lee J, Lee SH, Park MJ, Park JB. Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem Cells. PLoS Biol 2015; 13:e1002152. [PMID: 25992628 PMCID: PMC4439169 DOI: 10.1371/journal.pbio.1002152] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2014] [Accepted: 04/10/2015] [Indexed: 12/29/2022] Open
Abstract
Epidermal growth factor receptor variant III (EGFRvIII) has been associated with glioma stemness, but the direct molecular mechanism linking the two is largely unknown. Here, we show that EGFRvIII induces the expression and secretion of pigment epithelium-derived factor (PEDF) via activation of signal transducer and activator of transcription 3 (STAT3), thereby promoting self-renewal and tumor progression of glioma stem cells (GSCs). Mechanistically, PEDF sustained GSC self-renewal by Notch1 cleavage, and the generated intracellular domain of Notch1 (NICD) induced the expression of Sox2 through interaction with its promoter region. Furthermore, a subpopulation with high levels of PEDF was capable of infiltration along corpus callosum. Inhibition of PEDF diminished GSC self-renewal and increased survival of orthotopic tumor-bearing mice. Together, these data indicate the novel role of PEDF as a key regulator of GSC and suggest clinical implications. A permanently activated mutant form of the epidermal growth factor receptor found in glioblastoma promotes self-renewal and tumor progression by inducing autocrine signalling via pigment epithelium-derived factor (PEDF). Malignant gliomas are among the most lethal types of cancer, due in part to the stem-cell-like characteristics and invasive properties of the brain tumor cells. However, little is known about the underlying molecular mechanisms that govern such processes. Here, we identify pigment epithelium-derived factor (PEDF) as a critical factor controlling stemness and tumor progression in glioma stem cells. We found that PEDF is secreted from glioblastoma expressing EGFRvIII, a frequently occurring mutation in primary glioblastoma that yields a permanently activated epidermal growth factor receptor. We delineate an EGFRvIII-STAT3-PEDF signaling axis as a signature profile of highly malignant gliomas, which promotes self-renewal of glioma stem cells. Our results demonstrate a previously unprecedented function of PEDF and implicate potential therapeutic approaches against malignant gliomas.
Collapse
Affiliation(s)
- Jinlong Yin
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Gunwoo Park
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Tae Hoon Kim
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Jun Hee Hong
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Youn-Jae Kim
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Xiong Jin
- Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Korea
| | - Sangjo Kang
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Ji-Eun Jung
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
- Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Korea
| | - Jeong-Yub Kim
- Divisions of Radiation Cancer Research, Research Center for Radio-Senescence, Korea Institute of Radiological and Medical Sciences, Seoul, Korea
- Department of Pathology, College of Medicine, Korea University, Seoul, Korea
| | - Hyeongsun Yun
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Jeong Eun Lee
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
- Cancer Cell and Molecular Biology Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Minkyung Kim
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
| | - Junho Chung
- Department of Biochemistry and Molecular Biology, Seoul National University, College of Medicine, Seoul, Korea
- Department of Cancer Biology, Seoul National University College of Medicine, Seoul, Korea
| | - Hyunggee Kim
- Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Korea
| | - Ichiro Nakano
- Department of Neurological Surgery, The Ohio State University, Columbus, Ohio, United States of America
- James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America
| | - Ho-Shin Gwak
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Heon Yoo
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Byong Chul Yoo
- Colorectal Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyangi, Korea
| | - Jong Heon Kim
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
- Cancer Cell and Molecular Biology Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Eun-Mi Hur
- Center for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology, Seoul, Korea
- Department of Neuroscience, Korea University of Science and Technology, Daejeon, Korea
| | - Jeongwu Lee
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
| | - Seung-Hoon Lee
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
- * E-mail: (SHL); (MJP); (JBP)
| | - Myung-Jin Park
- Divisions of Radiation Cancer Research, Research Center for Radio-Senescence, Korea Institute of Radiological and Medical Sciences, Seoul, Korea
- * E-mail: (SHL); (MJP); (JBP)
| | - Jong Bae Park
- Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
- Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
- * E-mail: (SHL); (MJP); (JBP)
| |
Collapse
|
23
|
Shin JM, Hong JH, Ko JY, Ro YS, Kim JE. Erythematous vesiculopapular eruptions on the extremities. Clin Exp Dermatol 2015; 40:943-5. [PMID: 25960170 DOI: 10.1111/ced.12666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/09/2014] [Indexed: 11/26/2022]
Affiliation(s)
- J M Shin
- Department of Dermatology, Hanyang University Hospital, Seoul, Korea
| | - J H Hong
- Department of Dermatology, Hanyang University Hospital, Seoul, Korea
| | - J Y Ko
- Department of Dermatology, Hanyang University Hospital, Seoul, Korea
| | - Y S Ro
- Department of Dermatology, Hanyang University Hospital, Seoul, Korea
| | - J E Kim
- Department of Dermatology, Hanyang University Hospital, Seoul, Korea
| |
Collapse
|
24
|
Fan MS, Hong JH, Ng ML, Lee LK, Lui PK, Choy YH. Western Influences on Chinese Sexuality: Insights from a Comparison of the Sexual Behavior and Attitudes of Shanghai and Hong Kong Freshmen at Universities. ACTA ACUST UNITED AC 2015; 21:158-66. [PMID: 12291366 DOI: 10.1080/01614576.1995.11074148] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
25
|
Choi YJ, Lee SH, Lee JL, Ahn JH, Lee KH, You D, Hong B, Hong JH, Ahn H. Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10-17). Br J Cancer 2014; 112:260-5. [PMID: 25429526 PMCID: PMC4453451 DOI: 10.1038/bjc.2014.591] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2014] [Revised: 10/07/2014] [Accepted: 11/01/2014] [Indexed: 12/29/2022] Open
Abstract
Background: Pemetrexed has shown a favourable response rate of about 30% with minimal toxicity when used as a single agent for treatment of advanced urothelial carcinoma. This phase II study evaluated the efficacy and safety of pemetrexed plus cisplatin in advanced urothelial carcinoma. Methods: This multicentre, single-arm, open-label, phase II clinical trial enrolled patients who had advanced urothelial carcinoma, ECOG PS 0–2, and measurable disease. Pemetrexed 500 mg m−2 with cisplatin 70 mg m−2 on day 1 were administered every 3 weeks. The primary endpoint was the objective response rate (ORR). Secondary endpoints were progression-free survival (PFS), overall survival (OS), and toxicity. Results: A total of 42 patients were enrolled (median age, 66 years; ECOG 0–1, 100% visceral metastasis, 54.8% recurrent disease, 57.1%). Twenty-seven partial responses for an ORR of 64.3% (95% CI, 49.2%–77.0%) were documented. Seven patients had stable disease. Median PFS and OS were 6.9 (95% CI, 6.2–7.6) and 14.4 (95% CI, 10.4–18.4) months, respectively. Grade 3 or 4 neutropenia was observed in 28.6% of patients. No patients experienced febrile neutropenia. Conclusion: The combination of pemetrexed and cisplatin is active, and well tolerated in patients with advanced urothelial cancer as a first-line treatment.
Collapse
Affiliation(s)
- Y J Choi
- 1] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea [2] Division of Hemato-oncology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea
| | - S H Lee
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - J-L Lee
- 1] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea [2] Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - J-H Ahn
- 1] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea [2] Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - K-H Lee
- Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - D You
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - B Hong
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - J H Hong
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - H Ahn
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
26
|
Lee JH, Oh S, Lee WR, Ko WH, Kim KP, Lee KD, Jeon YM, Yoon SW, Cho KW, Narihara K, Yamada I, Yasuhara R, Hatae T, Yatsuka E, Ono T, Hong JH. Edge profile measurements using Thomson scattering on the KSTAR tokamak. Rev Sci Instrum 2014; 85:11D407. [PMID: 25430170 DOI: 10.1063/1.4890258] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
In the KSTAR Tokamak, a "Tangential Thomson Scattering" (TTS) diagnostic system has been designed and installed to measure electron density and temperature profiles. In the edge system, TTS has 12 optical fiber bundles to measure the edge profiles with 10-15 mm spatial resolution. These 12 optical fibers and their spatial resolution are not enough to measure the pedestal width with a high accuracy but allow observations of L-H transition or H-L transitions at the edge. For these measurements, the prototype ITER edge Thomson Nd:YAG laser system manufactured by JAEA in Japan is installed. In this paper, the KSTAR TTS system is briefly described and some TTS edge profiles are presented and compared against the KSTAR Charge Exchange Spectroscopy and other diagnostics. The future upgrade plan of the system is also discussed in this paper.
Collapse
Affiliation(s)
- J H Lee
- National Fusion Research Institute, Daejeon, South Korea
| | - S Oh
- National Fusion Research Institute, Daejeon, South Korea
| | - W R Lee
- National Fusion Research Institute, Daejeon, South Korea
| | - W H Ko
- National Fusion Research Institute, Daejeon, South Korea
| | - K P Kim
- National Fusion Research Institute, Daejeon, South Korea
| | - K D Lee
- National Fusion Research Institute, Daejeon, South Korea
| | - Y M Jeon
- National Fusion Research Institute, Daejeon, South Korea
| | - S W Yoon
- National Fusion Research Institute, Daejeon, South Korea
| | - K W Cho
- National Fusion Research Institute, Daejeon, South Korea
| | - K Narihara
- National Institute for Fusion Science, Nagoya, Japan
| | - I Yamada
- National Institute for Fusion Science, Nagoya, Japan
| | - R Yasuhara
- National Institute for Fusion Science, Nagoya, Japan
| | - T Hatae
- Japan Atomic Energy Agency, Naka, Japan
| | - E Yatsuka
- Japan Atomic Energy Agency, Naka, Japan
| | - T Ono
- Japan Atomic Energy Agency, Naka, Japan
| | - J H Hong
- Department of Physics, KAIST, South Korea
| |
Collapse
|
27
|
Seon CR, Hong JH, Jang J, Lee SH, Choe W, Lee HH, Cheon MS, Pak S, Lee HG, Biel W, Barnsley R. Test of prototype ITER vacuum ultraviolet spectrometer and its application to impurity study in KSTAR plasmas. Rev Sci Instrum 2014; 85:11E403. [PMID: 25430310 DOI: 10.1063/1.4886430] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
To optimize the design of ITER vacuum ultraviolet (VUV) spectrometer, a prototype VUV spectrometer was developed. The sensitivity calibration curve of the spectrometer was calculated from the mirror reflectivity, the grating efficiency, and the detector efficiency. The calibration curve was consistent with the calibration points derived in the experiment using the calibrated hollow cathode lamp. For the application of the prototype ITER VUV spectrometer, the prototype spectrometer was installed at KSTAR, and various impurity emission lines could be measured. By analyzing about 100 shots, strong positive correlation between the O VI and the C IV emission intensities could be found.
Collapse
Affiliation(s)
- C R Seon
- National Fusion Research Institute, Gwahangno 113, Yuseong-gu, Daejeon, South Korea
| | - J H Hong
- Korea Advanced Institute of Science and Technology, Gwahangno 335, Yuseong-gu, Daejeon, South Korea
| | - J Jang
- Korea Advanced Institute of Science and Technology, Gwahangno 335, Yuseong-gu, Daejeon, South Korea
| | - S H Lee
- Korea Advanced Institute of Science and Technology, Gwahangno 335, Yuseong-gu, Daejeon, South Korea
| | - W Choe
- Korea Advanced Institute of Science and Technology, Gwahangno 335, Yuseong-gu, Daejeon, South Korea
| | - H H Lee
- National Fusion Research Institute, Gwahangno 113, Yuseong-gu, Daejeon, South Korea
| | - M S Cheon
- National Fusion Research Institute, Gwahangno 113, Yuseong-gu, Daejeon, South Korea
| | - S Pak
- National Fusion Research Institute, Gwahangno 113, Yuseong-gu, Daejeon, South Korea
| | - H G Lee
- National Fusion Research Institute, Gwahangno 113, Yuseong-gu, Daejeon, South Korea
| | - W Biel
- Institut für Plasmaphysik, Forschungszentrum Jülich Gmbh, EURATOM Association, Trilateral Euregio Cluster, D-52425 Jülich, Germany
| | - R Barnsley
- ITER Organization, Cadarache Centre, 13108 Saint-Paul-Lez-Durance, France
| |
Collapse
|
28
|
Yim GJ, Cheong YW, Hong JH, Hur W. The role of each compartment in a two-compartment vertical flow reactor for ferruginous mine water treatment. Water Res 2014; 62:11-19. [PMID: 24929991 DOI: 10.1016/j.watres.2014.05.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/07/2013] [Revised: 04/24/2014] [Accepted: 05/12/2014] [Indexed: 06/03/2023]
Abstract
A vertical flow reactor (VFR) has been suggested for remediation of ferruginous mine drainage that passes down through an accreting bed of ochre. However, a VFR has a limited operation time until the system begins to overflow. In this study, a mathematical model was developed as a part of the effort to explore the operation of a VFR, showing dynamic changes in the head differences, ochre depths, and Fe(II)/Fe(III) concentrations in the effluent flow. The analysis showed that VFR operation time extended from 148.5 days to 163 days in an equally divided and to 168.4 days in asymmetrically (0.72:0.28) divided two-compartment VFR, suggesting that an optimum compartment ratio exists that maximizes the VFR operation time. A constant head filtration in the first compartment maximized filtration efficiency and thus prolonged VFR longevity in the two-compartment VFR. Fe(II) oxidation and ochre formation should be balanced with the permeability of the ochre bed to maximize the VFR operation time and minimize the residual Fe(II) in the effluent. Accelerated Fe(II) oxidation affected the optimum ratio of the compartment area and reduced the residual Fe(II) in the effluent. The VFR operation time can be prolonged significantly from 764 days to 3620 days by increasing the rate of ochre formation, much more than by accelerating the Fe(II) oxidation. During the prolonged VFR operation, ochre formed largely in the first compartment, while overflowing mine water with reduced iron content was effectively filtered in the second compartment. These results not only provide a better understanding of VFR operation but also suggest the direction of evolution of two-compartment VFR toward a compact and highly efficient facility integrated with an aerated cascade and with automatic coagulant feeding.
Collapse
Affiliation(s)
- G J Yim
- Geologic Environment Division, Korea Institute of Geoscience and Mineral Resources, 92 Gwahang-no, Yuseong-gu, Daejeon 305-350, Republic of Korea
| | - Y W Cheong
- Geologic Environment Division, Korea Institute of Geoscience and Mineral Resources, 92 Gwahang-no, Yuseong-gu, Daejeon 305-350, Republic of Korea
| | - J H Hong
- Mine Reclamation Corporation, 389-14 Seonghwan-eup Cheonan-si, Chungcheongnam-do 331-803, Republic of Korea
| | - W Hur
- Dept. of Bioengineering and Technology, Kangwon National University, 192-1 Hyoja-dong, Chuncheon, Kangwon-do 200-701, Republic of Korea.
| |
Collapse
|
29
|
Hong JH, Ahn M, Kim K, Jun SC. Localization of coherent sources by simultaneous MEG and EEG beamformer. Med Biol Eng Comput 2013; 51:1121-35. [PMID: 23793511 DOI: 10.1007/s11517-013-1092-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2013] [Accepted: 06/08/2013] [Indexed: 10/26/2022]
Abstract
Simultaneous magnetoencephalography (MEG) and electroencephalography (EEG) analysis is known generally to yield better localization performance than a single modality only. For simultaneous analysis, MEG and EEG data should be combined to maximize synergistic effects. Recently, beamformer for simultaneous MEG/EEG analysis was proposed to localize both radial and tangential components well, while single modality analyses could not detect them, or had relatively higher location bias. In practice, most interesting brain sources are likely to be activated coherently; however, conventional beamformer may not work properly for such coherent sources. To overcome this difficulty, a linearly constrained minimum variance (LCMV) beamformer may be used with a source suppression strategy. In this work, simultaneous MEG/EEG LCMV beamformer using source suppression was formulated firstly to investigate its capability over various suppression strategies. The localization performance of our proposed approach was examined mainly for coherent sources and compared thoroughly with the conventional simultaneous and single modality approaches, over various suppression strategies. For this purpose, we used numerous simulated data, as well as empirical auditory stimulation data. In addition, some strategic issues of simultaneous MEG/EEG analysis were discussed. Overall, we found that our simultaneous MEG/EEG LCMV beamformer using a source suppression strategy is greatly beneficial in localizing coherent sources.
Collapse
Affiliation(s)
- Jun Hee Hong
- School of Information and Communications, Gwangju Institute of Science and Technology, Gwangju, 500-712, Republic of Korea
| | | | | | | |
Collapse
|
30
|
Cho HJ, El-Gamal MI, Oh CH, Lee SH, Kim G, Hong JH, Choi HS, Yoo KH. Synthesis and Antiproliferative Activity of New Aminoisoquinolinylurea Derivatives against Melanoma Cell Line. B KOREAN CHEM SOC 2012. [DOI: 10.5012/bkcs.2012.33.11.3635] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
31
|
Jang EJ, Jeong H, Kang JO, Kim NJ, Kim MS, Choi SH, Yoo SE, Hong JH, Bae MA, Hwang ES. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ. Br J Pharmacol 2012; 165:1584-94. [PMID: 21913895 DOI: 10.1111/j.1476-5381.2011.01664.x] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
BACKGROUND AND PURPOSE The transcriptional co-activator with PDZ-binding motif (TAZ) is characterized as a transcriptional modulator of mesenchymal stem cell differentiation into osteoblasts and adipocytes. Moreover, increased TAZ activity in the nucleus enhances osteoblast differentiation and suppresses adipocyte development by interacting with runt-related transcription factor 2 (RUNX2) and PPARγ, respectively. Therefore, it would be of interest to identify low MW compounds that modulate nuclear TAZ activity. EXPERIMENTAL APPROACH High-throughput screening was performed using a library of low MW compounds in order to identify TAZ modulators that enhance nuclear TAZ localization. The effects and molecular mechanisms of a TAZ modulator have been characterized in osteoblast and adipocyte differentiation. KEY RESULTS We identified 2-butyl-5-methyl-6-(pyridine-3-yl)-3-[2'-(1H-tetrazole-5-yl)-biphenyl-4-ylmethyl]-3H-imidazo[4,5-b]pyridine] (TM-25659) as a TAZ modulator. TM-25659 enhanced nuclear TAZ localization in a dose-dependent manner and attenuated PPARγ-mediated adipocyte differentiation by facilitating PPARγ suppression activity of TAZ. In addition, TAZ-induced RUNX2 activity activation was further increased in osteoblasts, causing increased osteoblast differentiation. Accordingly, TM-25659 suppressed bone loss in vivo and decreased weight gain in an obesity model. After oral administration, TM-25659 had a favourable pharmacokinetic profile. CONCLUSION AND IMPLICATIONS TM-25659 stimulated nuclear TAZ localization and thus caused TAZ to suppress PPARγ-dependent adipogenesis and enhance RUNX2-induced osteoblast differentiation in vitro and in vivo. Our data suggest that TM-25659 could be beneficial in the control of obesity and bone loss.
Collapse
Affiliation(s)
- E J Jang
- College of Pharmacy and Division of Life and Pharmaceutical Sciences and Center for Cell Signaling and Drug Discovery Research, Ewha Womans University, Seoul Korea
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Lee JL, Ahn JH, Lim HY, Park SH, Lee SH, Kim TM, Lee DH, Cho YM, Song C, Hong JH, Kim CS, Ahn H. Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma. Ann Oncol 2012; 23:2108-2114. [PMID: 22228449 DOI: 10.1093/annonc/mdr586] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/06/2023] Open
Abstract
BACKGROUND Retrospective and molecular biologic data suggest that sunitinib may be effective in patients with non-clear cell renal cell carcinoma (nccRCC). PATIENTS AND METHODS Eligibility criteria included advanced nccRCC except for collecting duct carcinoma and sarcomatoid carcinoma without identifiable renal cell carcinoma subtypes. Patients were treated with 50 mg/day oral sunitinib for 4 weeks, followed by 2 weeks of rest. The primary end point was overall response rate (RR). RESULTS Thirty-one eligible patients were enrolled. Twenty-four patients (77%) had prior nephrectomy. By Memorial Sloan-Kettering Cancer Center criteria, 8 patients (26%) had poor risk and 14 (45%) had intermediate risk. Twenty-two patients had papillary renal cell carcinoma (RCC), and three had chromophobe RCC. Eleven patients had partial response with a RR of 36% (95% confidence interval (CI) 19% to 52%) and an additional 17 patients (55%) had stable disease. Median duration of response was 12.7 months (95% CI 6.3-19.1 months), and median progression-free survival was 6.4 months (95% CI 4.2-8.6 months). At a median follow-up duration of 18.7 months (95% CI 13.7-23.7 months), 13 patients (42%) had died, resulting in an estimated median survival of 25.6 months (95% CI 8.4-42.9 months). Toxicity profiles were commensurate with prior reports. CONCLUSIONS Sunitinib has promising activity in patients with nccRCC (NCT01219751).
Collapse
Affiliation(s)
- J-L Lee
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
| | - J-H Ahn
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
| | - H Y Lim
- Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul
| | - S H Park
- Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul
| | - S H Lee
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul
| | - T M Kim
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul
| | - D-H Lee
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
| | - Y M Cho
- Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
| | - C Song
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - J H Hong
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - C-S Kim
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - H Ahn
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| |
Collapse
|
33
|
Ahn M, Hong JH, Jun SC. Feasibility of approaches combining sensor and source features in brain–computer interface. J Neurosci Methods 2012; 204:168-178. [PMID: 22108142 DOI: 10.1016/j.jneumeth.2011.11.002] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2011] [Revised: 10/28/2011] [Accepted: 11/02/2011] [Indexed: 11/29/2022]
Affiliation(s)
- Minkyu Ahn
- School of Information and Communications, Gwangju Institute of Science and Technology, South Korea
| | - Jun Hee Hong
- School of Information and Communications, Gwangju Institute of Science and Technology, South Korea
| | - Sung Chan Jun
- School of Information and Communications, Gwangju Institute of Science and Technology, South Korea.
| |
Collapse
|
34
|
Abstract
Influx of Ca(2+) is a central component of the receptor-evoked Ca(2+) signal. A ubiquitous form of Ca(2+) influx comes from Ca(2+) channels that are activated in response to depletion of the endoplasmic reticulum Ca(2+) stores and are thus named the store-operated Ca(2+) -influx channels (SOCs). One form of SOC is the transient receptor potential canonical (TRPC) channels. A major question in the field of Ca(2+) signalling is the molecular mechanism that regulates the opening and closing of these channels. All TRPC channels have a Homer-binding ligand and two conserved negative charges that interact with two terminal lysines of the stromal interacting molecule 1 (STIM1). The Homer and STIM1 sites are separated by only four amino acid residues. Based on available results, we propose a molecular mechanism by which Homer couples TRPC channels to IP(3) receptors (IP(3) Rs) to keep these channels in the closed state. Dissociation of the TRPCs-Homer-IP(3) Rs complex allows STIM1 access to the TRPC channels negative charges to gate open these channels.
Collapse
Affiliation(s)
- J P Yuan
- Department of Integrative Physiology, University of North Texas Health Science Center, Fort Worth, Texas, USA
| | | | | | | |
Collapse
|
35
|
El-Gamal MI, Choi HS, Cho HG, Hong JH, Yoo KH, Oh CH. Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line. Arch Pharm (Weinheim) 2011; 344:745-54. [PMID: 21954060 DOI: 10.1002/ardp.201000375] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2010] [Revised: 01/12/2011] [Accepted: 01/19/2011] [Indexed: 11/09/2022]
Abstract
Synthesis of a new series of 3,4-diarylpyrazole-1-carboxamide derivatives is described. Their antiproliferative activity against A375P human melanoma cell line was tested and the effect of substituents on the diarylpyrazole scaffold was investigated. The biological results indicated that five synthesized compounds (Ig, Ii, IIc, IIg, and IIh) exhibited similar activity to Sorafenib. In addition, three compounds (IIa, IIb, and IIi) were more potent than Sorafenib. Among all of these derivatives, compound IIa which has dimethylamino and phenolic moieties showed the most potent antiproliferative activity against A375P human melanoma cell line. Virtual screening was carried out through docking of the most potent compound IIa into the domain of V600E-b-Raf and the binding mode was studied.
Collapse
Affiliation(s)
- Mohammed I El-Gamal
- Department of Biomolecular Science, University of Science and Technology, Daejeon, Republic of Korea
| | | | | | | | | | | |
Collapse
|
36
|
Kwon HG, Hong JH, Jang SH. Anatomic location and somatotopic arrangement of the corticospinal tract at the cerebral peduncle in the human brain. AJNR Am J Neuroradiol 2011; 32:2116-9. [PMID: 21903908 DOI: 10.3174/ajnr.a2660] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
BACKGROUND AND PURPOSE Little is known about the detailed anatomic location and somatotopic arrangement at the CP. Using DTT with FSL tools, we conducted an investigation of the anatomic location and somatotopic arrangement of the CST at the CP in the human brain. MATERIALS AND METHODS We recruited 43 healthy volunteers for this study. DTI was obtained by using 1.5T, and CSTs for the hand and leg were obtained by using the FSL tool. The somatotopic location of the CST was evaluated as the highest probabilistic location at the upper and lower midbrain. The posterior boundary was determined as the line between the interpeduncular fossa and the lateral sulcus; we then drew a rectangle on the basis of the boundary of the CP. RESULTS In the mediolateral direction, the highest probabilistic locations for the hand and leg were an average of 60.46% and 69.98% from the medial boundary at the upper midbrain level and 53.44% and 62.76% at the lower midbrain level, respectively. As for the anteroposterior direction, the highest probabilistic locations for the hand and leg were an average of 28.26% and 32.03% from the anterior boundary at the upper midbrain level and 30.19% and 33.59% at the lower midbrain level, respectively. CONCLUSIONS We found that the hand somatotopy for the CST is located at the middle portion of the CP and the leg somatotopy is located lateral to the hand somatotopy.
Collapse
Affiliation(s)
- H G Kwon
- Department of Physical Therapy, Daegu University, Daegu, Republic of Korea
| | | | | |
Collapse
|
37
|
Hong JH, Kwon HG, Jang SH. Probabilistic somatotopy of the spinothalamic pathway at the ventroposterolateral nucleus of the thalamus in the human brain. AJNR Am J Neuroradiol 2011; 32:1358-62. [PMID: 21596807 DOI: 10.3174/ajnr.a2497] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE The STP has been regarded as the most plausible neural tract responsible for pathogenesis of central poststroke pain. The VPL nucleus has been a target for neurosurgical procedures for control of central poststroke pain. However, to our knowledge, no DTI studies have been conducted to investigate the somatotopic location of the STP at the VPL nucleus of the thalamus. In the current study, we attempted to investigate this location in the human brain by using a probabilistic tractography technique of DTI. MATERIALS AND METHODS DTI was performed at 1.5T by using a Synergy-L SENSE head coil. STPs for both the hand and leg were obtained by selection of fibers passing through 2 regions of interest (the area of the spinothalamic tract in the posterolateral medulla and the postcentral gyrus) for 41 healthy volunteers. Somatotopic mapping was obtained from the highest probabilistic location at the ACPC level. RESULTS The highest probabilistic locations for the hand and leg were an average of 16.86 and 16.37 mm lateral to the ACPC line and 7.53 and 8.71 mm posterior to the midpoint of the ACPC line, respectively. Somatotopic locations for the hand and leg were different in the anteroposterior direction (P < .05); however, no difference was observed in the mediolateral direction (P > .05). CONCLUSIONS We found the somatotopic locations for hand and leg of the STP at the VPL nucleus; these somatotopies were arranged in the anteroposterior direction.
Collapse
Affiliation(s)
- J H Hong
- Department of Physical Therapy, Yeungnam College of Science and Technology, Daegu, Republic of Korea
| | | | | |
Collapse
|
38
|
Hong JH, Yoon EK, Chung SJ, Chung L, Cha SM, O'Mahony M, Vickers Z, Kim KO. Sensory characteristics and cross-cultural consumer acceptability of Bulgogi (Korean traditional barbecued beef). J Food Sci 2011; 76:S306-13. [PMID: 22417445 DOI: 10.1111/j.1750-3841.2011.02173.x] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
UNLABELLED Bulgogi (Korean traditional barbecued beef) is the most well-known Korean food to foreigners. There are, however, few studies on its sensory characteristics and consumer acceptability. This study was performed to identify the sensory attributes of Bulgogi samples prepared with different formulation and to compare the consumer acceptability in Korea and the United States. Bulgogi samples were prepared with varying levels of sugar and soy sauce with/without garlic or sesame oil. Descriptive analysis was conducted by 8 trained panelists. In consumer tests, 42 consumers in Seoul, Korea, 53 consumers in Davis (Calif., U.S.A.), and 39 consumers in St. Paul (Minn., U.S.A.) participated. Higher levels of sugar and soy sauce (SSS) significantly increased sweetness, saltiness, MSG taste, and soy sauce odor/flavor compared to the control made with the standard formula (CON). Elimination of sesame oil (ESO) significantly decreased sesame oil odor/flavor and oiliness, but increased green onion flavor. Elimination of garlic (EGC) significantly increased grilled beef odor/flavor, sesame oil odor/flavor, and oiliness, but decreased intensities of all the other attributes except bitterness. The consumers in Korea and the United States rated their overall liking for all samples similarly, preferring SSS to CON, EGC, and ESO. However Korean consumers seemed to detect the differences caused by formulation changes better than the U.S. consumers and these perceived differences seemed to impact the hedonic and the just-about-right ratings. Increase in soy sauce and sugar increased both Korean and the U.S. consumers' acceptability of Bulgogi, whereas eliminating garlic did not influence the consumer acceptability despite of its significant impact on sensory attributes. PRACTICAL APPLICATION The food industry is increasingly interested in ethnic foods that satisfy sophisticated appetite of today's consumers. Korean cuisine is recently gaining popularity and perceived as "adventurous and spicy," appealing to researchers and marketers in the food industry worldwide. However, it is not easy to develop a new product based on ethnic cuisine because nonsensory factors, such as food neophobia and openness to new culture, can evoke adverse responses from the consumers. A systematic sensory approach can guide the product development by identifying both sensory and nonsensory factors affecting consumer acceptability. This study investigated sensory attributes of Bulgogi (Korean traditional barbecued beef), one of the most famous Korean foods, and compared consumer acceptability between Korea and the United States. The outcomes of this study, such as flavor profiles, consumer responses, evaluation procedure, and approaches taken for cross-cultural comparison, will provide the food industries with valuable information that will help to develop effective strategies for commercializing ethnic foods including recipe development for Bulgogi marinades.
Collapse
Affiliation(s)
- J H Hong
- Dept. of Food Science and Enginering, Ewha Womans Univ., 11-1 Daehyun-Dong, Seodaemun-Gu, Seoul 120-750, Korea
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Abstract
This paper is about a glass-type wireless bio-signal transmitter that can monitor the user's health state in daily life. The device implemented in this study consists of the transmission part and the receiving part. The transmission part includes a photoplethysmography(PPG) sensor for detecting pulse wave signals, accelerometer for detecting kinetic signals, and a wireless controller for transmitting acquired bio-information. The receiving part is designed to check and process transmitted data through interoperation with a PC. In the experiments, we collected data during a sitting posture and repeated sit-to-stand motion in laboratory environment, and analyzed the data. As to accuracy, the correlation between the peak-to-peak intervals in the signals of the Biopac equipment and the developed device measured in a sitting posture was 97.5%, and that measured in sit-to-stand motion was 87%. In addition, when bio-signals were transmitted through wireless communication, the transmission was successful 100% without any error. When pulse wave signals and kinetic signals were obtained and compared, the results proved the accuracy and daily applicability of the developed device, and the glass-type wireless bio-signal transmission system is expected to be applicable to unobtrusive health monitoring for the user.
Collapse
Affiliation(s)
- E M Lee
- Department of Biomedical Engineering, College of Medicine, Chungbuk National University, South Korea.
| | | | | | | | | |
Collapse
|
40
|
Hong JH, Song SH, Kim SE, Lee JK, Lee NW, Lee KW. Diffuse intraabdominal fibrosis and inflammation mimicking peritoneal carcinomatosis recurred after surgery for borderline ovarian tumor misdiagnosed by 18F-fluorodeoxyglucose-positron emission tomography. EUR J GYNAECOL ONCOL 2011; 32:231-233. [PMID: 21614927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
BACKGROUND 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) adds to conventional imaging in the detection and staging of peritoneal carcinomatosis. CASE REPORT Herein we report a 27-year-old woman with multiple intraperitoneal masses detected by 18F-FDG-PET, suggesting peritoneal carcinomatosis. She had undergone laparoscopic unilateral oophorectomy for a left ovarian mucinous borderline tumor approximately five years before. Based on imaging and intraoperative findings, multiple intraabdominal masses strongly suggested peritoneal recurrence from a previous ovarian borderline tumor, but it finally proved to be inflammation and fibrosis on histopathologic examination. CONCLUSION Although 18F-FDG-PET is well known to be a highly sensitive imaging tool for identification of peritoneal carcinomatosis, FDG uptake is not tumor-specific. Therefore, the possibility of a false-positive diagnosis due to benign conditions, such as inflammation, should always be taken into consideration.
Collapse
Affiliation(s)
- J H Hong
- Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
| | | | | | | | | | | |
Collapse
|
41
|
Hong JH, Song SH, Lee JK, Lee NW, Lee KW. Metastatic cervical adenocarcinoma mimicking retroperitoneal sarcoma of the psoas muscle on imaging. EUR J GYNAECOL ONCOL 2011; 32:221-223. [PMID: 21614923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
BACKGROUND The incidence of bone metastasis is low in metastatic cervical cancer, especially in the case of adenocarcinoma. Incidental finding of a mass located in an unusual metastatic site in the absence of identifiable primary tumor often results in a difficult diagnostic problem. CASE REPORT We report the case of a 59-year-old woman presenting left-sided foot drop as her initial symptom. At first, after performing lumbar spine magnetic resonance imaging (MRI), a huge paravertebral mass with ipsilateral psoas muscle involvement suggesting retroperitoneal sarcoma was identified. However, cervical punch biopsy and sono-guided paravertebral mass biopsy revealed cervical adenocarcinoma with lumbar spinal metastasis. CONCLUSION Although rare, a neurological symptom such as foot drop, not vaginal symptoms, in a woman may be a first manifestation of metastatic cervical cancer, especially in spinal metastasis. Furthermore, any abnormal lesion should not be ignored because of the possibility of metastasis from the primary malignancy, especially in the current case of cervical adenocarcinoma, so a complete evaluation is always mandatory.
Collapse
Affiliation(s)
- J H Hong
- Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
| | | | | | | | | |
Collapse
|
42
|
Hsu LH, Chen YP, Chang HP, Chen YR, Hong JH, Chao A, Lai CH. Successful salvage treatment of recurrent endometrial cancer with multiple lung and abdominal metastases. EUR J GYNAECOL ONCOL 2011; 32:218-220. [PMID: 21614922] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
The prognosis of recurrent endometrial carcinoma is generally poor except for isolated vaginal or pelvic relapse without previous radiation. Recurrences associated with infield failure or distant metastasis carry a poor prognosis. We report a case of recurrent endometrial carcinoma treated with cytoreductive surgery, targeted radiation to lung metastasis defined by CT and PET and adjuvant chemo-hormone therapy followed by maintenance progestin therapy with a good outcome. This case implied that chemo-hormone therapy with targeted radiation should be evaluated in recurrent endometrial cancer with positive progesterone receptor for salvage treatment.
Collapse
Affiliation(s)
- L H Hsu
- Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan
| | | | | | | | | | | | | |
Collapse
|
43
|
El-Gamal MI, Sim TB, Hong JH, Cho JH, Yoo KH, Oh CH. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line. Arch Pharm (Weinheim) 2010; 344:197-204. [PMID: 21384419 DOI: 10.1002/ardp.201000057] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2010] [Revised: 04/26/2010] [Accepted: 04/26/2010] [Indexed: 11/06/2022]
Abstract
Synthesis of a new series of 1H-pyrazole-1-carboxamide derivatives is described. Their antiproliferative activity against A375 human melanoma cell line was tested and the effect of substituents on the diarylpyrazole scaffold was investigated. The pharmacological results indicated that most of the newly synthesized compounds showed moderate activity against A375, compared with sorafenib. Among all of these derivatives, compound IIe which has N-methylpiperazinyl and phenolic moieties showed the most potent antiproliferative activity against A375 human melanoma cell line.
Collapse
Affiliation(s)
- Mohammed I El-Gamal
- Biomaterials Center, Korea Institute of Science and Technology, Cheongryang, Seoul, Republic of Korea
| | | | | | | | | | | |
Collapse
|
44
|
Choi HY, Lim JE, Hong JH. Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells. Prostate Cancer Prostatic Dis 2010; 13:343-9. [PMID: 20680030 DOI: 10.1038/pcan.2010.26] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Recently, studies have investigated the significance of the Wnt/β-catenin pathway in prostate cancer. The transcriptional activity of the androgen receptor (AR) is modulated by interaction with coregulators, one of which is β-catenin. Curcumin, a dietary yellow pigment of Curcuma longa, has emerged as having a chemopreventive role. Although curcumin has been shown to inhibit AR expression, its molecular mechanism has not been fully elucidated. In this study, whether curcumin mediates the Wnt/β-catenin signaling pathway with regard to AR/β-catenin interactions was studied. Curcumin was shown to induce significant inhibition of AR expression in a dose-dependent manner. Marked curcumin-induced suppression of β-catenin was shown in the nuclear and cytoplasmic extracts as well as whole cell lysates. Further analysis revealed that phosphorylation of Akt and glycogen synthase kinase-3β were attenuated, but phosphorylated β-catenin was increased after curcumin treatment. Finally, cyclin D1 and c-myc, the target gene of the β-catenin/T-cell factor transcriptional complex, were also decreased. These findings suggest that curcumin modulates the Wnt/β-catenin signaling pathway and might have a significant role in mediating inhibitory effects on LNCaP prostate cancer cells.
Collapse
Affiliation(s)
- H Y Choi
- Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | | | | |
Collapse
|
45
|
Won M, Park KA, Byun HS, Sohn KC, Kim YR, Jeon J, Hong JH, Park J, Seok JH, Kim JM, Yoon WH, Jang IS, Shen HM, Liu ZG, Hur GM. Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation. Cell Death Differ 2010; 17:1830-41. [PMID: 20448643 DOI: 10.1038/cdd.2010.47] [Citation(s) in RCA: 74] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
The zinc-finger protein A20 has crucial physiological functions as a dual inhibitor of nuclear factor-κB (NF-κB) activation and apoptosis in tumor necrosis factor (TNF) receptor 1 signaling pathway. Although the molecular basis for the anti-NF-κB function of A20 has been well elucidated, the anti-apoptotic function of A20 is largely unknown. Here, we report a novel mechanism underlying the anti-apoptotic function of A20: A20 blocks TNF-induced apoptosis through suppression of c-jun N-terminal kinase (JNK) by targeting apoptosis signal-regulating kinase1 (ASK1). First, the ectopic expression of A20 drastically inhibits TNF-induced JNK activation and apoptosis in multiple cell types including those deficient of NF-κB activation. Unexpectedly, the blunting effect of A20 on TNF-induced JNK activation is not mediated by affecting the TNFR1 signaling complex formation. Instead, A20 interacts with ASK1, an important MAPKK kinase in the JNK signaling cascade. More importantly, overexpression of wild-type A20, but not of mutant A20 (ZnF4; C624A, C627A), promotes degradation of the ASK1 through the ubiquitin-proteasome system. Taken together, the results from this study reveal a novel anti-apoptotic mechanism of A20 in TNF signaling pathway: A20 binds to ASK1 and mediates ASK1 degradation, leading to suppression of JNK activation and eventually blockage of apoptosis.
Collapse
Affiliation(s)
- M Won
- Department of Pharmacology, Research Institute for Medical Science, Infection Signaling Network Research Center, Daejeon Regional Cancer Center, College of Medicine, Chungnam National University, Daejeon, Korea
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Hall MN, Rosenkrantz WS, Hong JH, Griffin CE, Mendelsohn CM. Evaluation of the potential use of adipose-derived mesenchymal stromal cells in the treatment of canine atopic dermatitis: a pilot study. Vet Ther 2010; 11:E1-E14. [PMID: 20957613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Stem cells and their potential therapeutic uses in human and veterinary medicine have generated considerable interest. These cells have a number of potentially unique immunologic properties; most notable are their reported regenerative and antiinflammatory capabilities. The aim of this prospective pilot study was to evaluate the efficacy of intravenously administered autogenous adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment of canine atopic dermatitis. AD-MSCs administered intravenously at a dose of 1.3 million cells/kg did not significantly reduce the clinical signs of canine atopic dermatitis or the owner-assessed pruritus level.
Collapse
Affiliation(s)
- M N Hall
- Animal Dermatology Clinic, Tustin, CA 92780, USA
| | | | | | | | | |
Collapse
|
47
|
Chao TC, Chen AM, Tu SJ, Tung CJ, Hong JH, Lee CC. The evaluation of 6 and 18 MeV electron beams for small animal irradiation. Phys Med Biol 2009; 54:5847-60. [DOI: 10.1088/0031-9155/54/19/012] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
48
|
Byun HS, Song JK, Kim YR, Piao L, Won M, Park KA, Choi BL, Lee H, Hong JH, Park J, Seok JH, Lee YJ, Kang SW, Hur GM. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford) 2008; 47:301-8. [PMID: 18276737 DOI: 10.1093/rheumatology/kem368] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVE Resveratrol is a naturally occurring polyphenol, which possesses chemotherapeutic potential through its ability to trigger apoptosis. The objective of this study was to investigate the major determinant for the apoptotic cell death induction by resveratrol in fibroblast-like synoviocytes (FLS) derived from patients with RA. METHODS The effect of resveratrol on apoptotic cell death was quantified in a population of subG1 in RA FLS by flow cytometry. The underlying signalling mechanism for apoptotic death was examined by analysing mitochondrial membrane potential, activation of the caspase cascade and translocation of Bid. RESULTS We show that activation of caspase-8 is essential for triggering resveratrol-induced apoptotic signalling via the involvement of the mitochondrial pathway in RA FLS. Our findings also suggest that this enhanced apoptosis caused by resveratrol occurred in RA FLS irrespective of p53 status. Exposure to resveratrol caused extensive apoptotic cell death, along with a caspase-dependent (activation of caspase-9 and -3, poly ADPribose polymerase (PARP) cleavage and mitochondrial cytochrome c release) or caspase-independent [translocation of apoptosis-inducing factor (AIF) to the nucleus] signalling pathway. Analysis of upstream signalling events affected by resveratrol revealed that the activated caspase-8 triggered mitochondrial apoptotic events by inducing Bid cleavage without any alteration in the levels of Bax, Bcl-xL or Bcl2. The caspase-8 inhibitor or over-expression of crmA abrogated cell death induced by resveratrol and prevented processing of the downstream cascade. CONCLUSION The results suggest that resveratrol causes activation of caspase-8, which in turn results in modulation of mitochondrial apoptotic machinery to promote apoptosis of RA FLS.
Collapse
Affiliation(s)
- H S Byun
- Department of Pharmacology, Infection Signaling Network Research Center, Research Institute for Medical Sciences, Daejeon, Korea
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Lee EM, Kim NH, Trang NT, Hong JH, Cha EJ, Lee TS. Respiratory rate detection algorithms by photoplethysmography signal processing. Annu Int Conf IEEE Eng Med Biol Soc 2008; 2008:1140-1143. [PMID: 19162865 DOI: 10.1109/iembs.2008.4649362] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Photoplethysmography (PPG) offers the clinically meaningful parameters, such as, heart rate, and respiratory rate. In this study, we presented three respiratory signal detection algorithms using photoplethysmography raw data generated from commercial PPG sensor: (1)Min-Max (2)Peak-to-Peak (3)Pulse Shape. As reference signal, nasal sensor signal was acquired simultaneously and compared and analyzed. We used two types of moving average filtering technique to process three PPG parameters. In laboratory experiment, 6 subjects' PPG signals were measured when they respire ten and fifteen, and arbitrary times per minute. From the results, following conclusions were drawn. Min-Max and Peak-to-Peak algorithms perform better than Pulse shape algorithm. They can be used to detect respiratory rate. But, Pulse Shape algorithm was accurate for subject 4 only. More experimental data is necessary to improve the accuracy and reliability.
Collapse
Affiliation(s)
- E M Lee
- Department of Biomedical Engineering, College of Medicine, Chungbuk National University, Cheongju, South Korea.
| | | | | | | | | | | |
Collapse
|
50
|
Min JW, Kong KA, Park BH, Hong JH, Park EA, Cho SJ, Ha EH, Park H. Effect of postnatal catch-up growth on blood pressure in children at 3 years of age. J Hum Hypertens 2007; 21:868-74. [PMID: 17476289 DOI: 10.1038/sj.jhh.1002215] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Size at birth and early postnatal growth rates appear to be important determinants of cardiovascular diseases. We examined whether intrauterine growth restriction or the subsequent catch-up postnatal weight gain leads to higher blood pressure in early life to confirm that size at birth and early postnatal growth rates appear to be important determinants of blood pressure changes in early life. Of 407 children born between December 2001 and November 2002 in hospital based-birth cohorts, 102 were followed up at 3 years of age (24.2%) at Ewha Womans University Hospital in Seoul, Korea. At 3 years of age, those who had a low birth weight still belonged in the lower-weight group than the others. The subjects' systolic blood pressure was correlated with their current weight (r=0.41) and weight gain (r=0.39), but not with their birth weight. Those with a higher current weight and higher weight gain based on birth weight (conditional weight gain) had the highest blood pressure. Systolic blood pressure increased by 0.2 mm Hg for every 100-g increase in weight at 3 years and, independently, by 1.5 mm Hg for every 100-unit increase in conditional weight gain. This study suggests that birth weight is not directly associated with blood pressure, but accelerated growth, which occurs mostly in those born with a low birth weight, seems to affect blood pressure in early life.
Collapse
Affiliation(s)
- J W Min
- Department of Preventive Medicine, School of Medicine, Ewha Womans University, Seoul, South Korea
| | | | | | | | | | | | | | | |
Collapse
|